Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Bushra Yousef

Bushra Yousef

Research Scientist UK

Isham Alzoubi

Isham Alzoubi

senior professor Saudi Arabia

Oleg Antnov

Oleg Antnov

Research Scientist Oman

Zeyad Ameena

Zeyad Ameena

Research Scientist Argentina

MUHAMMAD JEHANGIR

MUHAMMAD JEHANGIR

Research Scientist Pakistan

Amjad Islam Aqib

Amjad Islam Aqib

Professor Pakistan

Mahdi Javadzadeh

Mahdi Javadzadeh

senior scientist Iran

Yacob Mathai

Yacob Mathai

senior research Scientist Hong Kong

Recommended Global Pharma Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Pharma Conference 2024

Welcome Message

Welcome Message:

Welcome to the 2nd Global Pharmaceutical and Pharma Industry Conference, scheduled to unfold on April 18-19, 2024, in the vibrant city of Dubai, UAE! We are delighted to extend a warm welcome to pharmaceutical professionals, industry leaders, researchers, and enthusiasts from across the globe.
This conference promises to be an enriching experience, offering a platform for collaboration, knowledge exchange, and exploration of the latest trends and innovations in the pharmaceutical and pharma industry. Join us as we delve into discussions, presentations, and networking opportunities that will shape the future of this dynamic field.
We express our appreciation to all participants, sponsors, and organizers whose dedication has played a pivotal role in bringing this event to fruition. Prepare for two days of insightful sessions, engaging conversations, and the chance to connect with like-minded individuals who share a passion for advancing the pharmaceutical and pharma industry.

 

About Conference


The 2nd Global Pharmaceutical & Pharma Industry Conference will be held in Dubai,UAE on April 18-19,2024. Confronting Global Issues and Exploring Scientific Inquiry on Pharmaceutics is the conference's key focus. It covers a variety of significant sessions. Inspiring Keynote Presentations, Plenary Talks, Symposiums, Special Sessions, and Career Development Programmes to make this top conference a success, we have thought of engaging workshops and keynote speakers.

The goal of the PHARMA CONFERENCE 2024 Professionals from the academic, pharmaceutical industry Research and Development wings, API: Active Pharmaceutical Ingredients industry, Drug discovery laboratories, Formulations and NDDS domains will also be attending the conference. This conference will also feature senior executives and renowned researchers from the fields of pharmaceutical chemistry, quality control, and assurance, clinical trials, pharmaceutical covigilance, pharmaceutical manufacturing, pharmacognosy, biopharmaceutics, drug discovery, design and development, and pharmacoeconomics.

Why to Attend?

The Pharma Conference 2024 will serve as a forum for discussion of new advancements in pharmaceutical science. The conference's characteristics include internationally renowned speakers, the most recent scientific discoveries, and consequently the most recent business developments in the pharmaceutical industry. The two-day event on pharmaceutical sciences may have more than 60 logical and focused talks and sub-sessions on cutting-edge global research projects in the subject. Find the most inventive and recent advancements in pharmaceutical technology and network with internationally renowned professionals and learn more about the direction and range of pharmaceutical investigations and talk about the development and importance of pharmaceutics amass and disseminate information.

Target Audience:

  • Pharmacists
  • Pharmaceutical Researchers
  • Professors and Associate Professors
  • Directors and CEO's of Organizations
  • Pharmaceutical societies, Associations
  • Physicians and clinical pharmacists
  • Pharmacologists
  • Nanotechnologists
  • Pharma Researchers
  •  Pharma Scientist
  •  Pharmaceutical professionals (CEOs, MDs, Directors)
  •  Drug development and Discovery companies
  •  Pharmaceutical Associations and Societies
  •  Formulation and Pharma Manufacturing companies
  •  Medical Technology companies
  •  Chemist
  •  Microbiologist
  •  Biotechnologists
  •  Biochemist
  •  Post-Doctoral
  •  Health care Professionals
  •  Genomics ad Personalised medicines Experts
  •  Professors
  •  Industrial Experts
  •  Academicians
  •  Pharmaceutical Development companies
  •  Doctors
  •  Biomaterial scientists and Nanotechnologists

SessionsTracks

1. Pharmaceutical Innovation: Pharmaceutical innovation refers to the process of discovering, developing, and bringing new drugs and medical treatments to the market. It encompasses the entire lifecycle of a pharmaceutical product, from initial research and development through clinical trials to regulatory approval and commercialization. Innovation in the pharmaceutical industry involves the application of scientific knowledge, technological advancements, and creative approaches to address unmet medical needs and improve patient outcomes.
 
2. Drug Discovery: Drug discovery is the process by which new medications or therapeutic compounds are identified, designed, and developed for treating diseases. It is a complex and multifaceted undertaking that involves several stages, from the initial identification of a potential drug target to the eventual introduction of a new drug to the market.
Here's an overview of the key steps in the drug discovery process:
  • Target Identification and Validation
  • Preclinical Testing
  • Clinical Trials
  • Regulatory Approval
  • Market Introduction
 
3. Precision medicine: Precision medicine, also known as personalized medicine, is an innovative approach to medical treatment and healthcare that takes into account individual differences in patients' genes, environments, and lifestyles. The goal of precision medicine is to tailor medical care and interventions to the specific characteristics of each patient, allowing for more accurate predictions of disease risk, targeted therapies, and optimized treatment outcomes.
 
 
4. Regulatory compliance: Regulatory compliance refers to the adherence of an organization to laws, regulations, guidelines, and specifications relevant to its business operations. This is crucial in various industries, including finance, healthcare, manufacturing, and technology, where specific rules are in place to ensure ethical conduct, data security, product safety, and overall responsible business practices.
 
5. Quality Assurance: Quality assurance (QA) is a systematic process implemented by organizations to ensure that products or services meet specified quality standards and comply with customer expectations. QA is an integral part of various industries, including manufacturing, healthcare, software development, and many others.
Here are key aspects related to quality assurance:
  • Definition of Standards
  • Process Monitoring
  • Preventive Measures
  • Documentation and Record Keeping
  • Employee Training
  • Customer Feedback and Satisfaction
  • Continuous Improvement
  • Compliance with Standards and Regulations
  • Quality Control vs. Quality Assurance
  • Automation in QA
6. Patient-centric healthcare: Patient-centric healthcare is an approach to the delivery of medical services that prioritizes the individual needs, preferences, and experiences of patients. It emphasizes a shift from a provider-focused model to one that actively involves and engages patients in their healthcare.
7. Biopharmaceuticals: Biopharmaceuticals, also known as biologics, are medicinal products derived from living organisms or biological systems. Unlike traditional pharmaceuticals, which are typically chemically synthesized, biopharmaceuticals are produced through biotechnological processes involving living cells. These products are a critical and rapidly growing component of modern medicine, contributing significantly to the treatment of various diseases.
  • Biological Sources
  • Types of Biopharmaceuticals
    1. Monoclonal antibodies
    2. Recombinant proteins
    3. Vaccines
    4. Gene therapies
    5. Nucleic acid-based therapies (RNA and DNA)
  • Therapeutic Applications
  • Biotechnological Production
  • Regulation and Approval
  • Challenges and Opportunities
  • Cost and Accessibility
  • Future Trends
8. Digital Transformation: Digital transformation refers to the integration of digital technologies into various aspects of an organization's operations, processes, strategies, and culture to fundamentally change the way it delivers value to its customers and stakeholders. It involves leveraging technological advancements to improve efficiency, enhance customer experiences, and adapt to the rapidly evolving digital landscape.
Here are the key aspects of digital transformation:
  • Technological Integration
  • Process Optimization
  • Customer-Centricity
  • Data-Driven Decision-Making
  • Agile and Innovative Culture
  • Ecosystem Connectivity
  • Cybersecurity and Risk Management
  • Multi-Channel Engagement
  • Adaptation to Change
  • Strategic Planning
9. Global Collaboration: Global collaboration in the pharmaceutical and pharma industries is crucial for addressing complex challenges, advancing scientific research, and ensuring equitable access to healthcare solutions on a global scale.
Here are key aspects of global collaboration in these industries:
  • Research and Development
  • Clinical Trials and Regulatory Approval
  • Knowledge Sharing and Data Exchange
  • Public-Private Partnerships
  • Supply Chain Collaboration
  • Access to Medicines
  • Vaccine Development and Distribution
  • Healthcare Infrastructure Development
10. Sustainable Pharma: "Sustainable pharma" refers to efforts within the pharmaceutical industry to integrate environmentally and socially responsible practices into various aspects of drug development, manufacturing, distribution, and overall business operations. This approach aims to minimize the industry's environmental impact, promote ethical and socially responsible practices, and contribute to long-term societal well-being.
Here are key aspects of sustainable pharma:
  • Green Chemistry and Manufacturing
  • Reducing Carbon Footprint
  • Waste Reduction and Recycling
  • Access to Medicines
  • Research for Global Health
  • Patient-Centric Sustainability
  • Transparency and Reporting
  • Stakeholder Engagement
11. Pharma Ethics: Pharmaceutical ethics, also known as pharma ethics, encompasses the moral principles, values, and guidelines that govern ethical behavior within the pharmaceutical industry. These ethical considerations are crucial to ensure the well-being of patients, uphold public trust, and maintain the integrity of the healthcare system.
Here are key aspects of pharmaceutical ethics:
  • Patient Welfare
  • Research Integrity
  • Informed Consent
  • Privacy and Confidentiality
  • Fair Marketing Practices
  • Access to Medicines
  • Compliance with Regulations
  • Anti-Bribery and Corruption
  • Equitable Access to Clinical Trials
  • Professional Integrity
12. Emerging markets: The pharmaceutical and pharma industries are witnessing significant growth and opportunities in emerging markets. Several factors contribute to the prominence of these markets in the pharmaceutical sector:
  • Increasing Healthcare Needs
  • Rising Middle Class
  • Access to Medicines
  • Government Initiatives
  • Clinical Trials and Research Opportunities
  • Local Production and Manufacturing
  • Partnerships and Collaborations
  • Generic Drug Manufacturing
  • Healthcare Infrastructure Investment
  • Disease Prevention and Vaccination Programs
13. Pharmacovigilance: Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. It is a critical component of drug safety monitoring throughout the lifecycle of pharmaceutical products.
Here are the key aspects of pharmacovigilance:
  • Adverse Drug Reaction (ADR) Monitoring
  • Data Collection and Analysis
  • Signal Detection
  • Risk Assessment and Management
  • Regulatory Reporting
  • Pharmacovigilance in Clinical Trials
  • Pharmacovigilance in Herbal Medicines and Vaccines
  • Technology and Automation
14. Clinical Trials: Clinical trials are research studies that involve human participants to evaluate the safety and efficacy of medical interventions such as drugs, devices, treatments, or preventive measures. These trials are conducted to gather scientific data that can contribute to medical knowledge and inform healthcare practices.
Here are key aspects of clinical trials:
  • Phases of Clinical Trials
  • Informed Consent
  • Randomized Controlled Trials (RCTs)
  • Placebo-Controlled Trials
  • Endpoints and Outcomes
  • Principal Investigator (PI)
  • Monitoring and Data Collection
  • Regulatory Approval
  • Patient Recruitment and Retention
  • Post-Marketing Surveillance
15. Pharmaceutical manufacturing: Pharmaceutical manufacturing is the process of producing pharmaceutical drugs on a large scale, encompassing the various stages involved in the production of pharmaceutical products. This highly regulated and complex process ensures the quality, safety, and efficacy of medications.
Here are key aspects of pharmaceutical manufacturing:
  • Drug Development and Formulation
  • Raw Material Sourcing
  • Quality Control and Assurance
  • Granulation and Blending
  • Tablet Compression or Capsule Filling
  • Sterile Manufacturing
  • Packaging and Labeling
  • Quality Testing
  • Regulatory Compliance
  • Continuous Manufacturing
  • Environmental Considerations
  • Technology and Automation
  • Supply Chain Management
16. Personalized medicine: Personalized medicine, also known as precision medicine, is an innovative approach to medical treatment that tailors healthcare decisions, practices, interventions, and pharmaceuticals to the individual patient. It takes into account the unique characteristics of each person, such as their genetic makeup, lifestyle, environment, and other factors.
Here are key aspects of personalized medicine:
  • Genomic Information
  • Biomarker Identification
  • Targeted Therapies
  • Pharmacogenomics
  • Diagnostics and Imaging
  • Tailored Treatment Plans
  • Cancer Genomics
  • Predictive Modeling
  • Patient Engagement
  • Preventive Medicine
  • Challenges and Ethical Considerations
  • Cost Considerations
17. Health Security: Health security refers to measures and initiatives aimed at safeguarding the health of individuals and communities from threats that can have significant public health consequences. These threats may arise from various sources, including infectious diseases, bioterrorism, natural disasters, and other emergencies. The goal of health security is to prevent, detect, respond to, and recover from health-related emergencies while ensuring the resilience of health systems.
Here are key aspects of health security:
  • Disease Surveillance and Early Warning Systems
  • Pandemic Preparedness
  • Emergency Response Planning
  • Public Health Infrastructure
  • International Collaboration
  • Capacity Building
  • Vaccination Programs
  • Risk Communication
  • Research and Development
  • Cross-Sectoral Collaboration
  • Legal and Regulatory Frameworks
  • Surge Capacity
  • Resilience and Adaptability
18. Pharmacoeconomics: Pharmacoeconomics is a branch of health economics that focuses on the economic evaluation of pharmaceuticals and healthcare interventions. It involves the application of economic principles and methods to assess the value, costs, and outcomes associated with the use of medications and healthcare services. The goal is to inform decision-making by healthcare providers, payers, policymakers, and patients.
Here are key aspects of pharmacoeconomics:
  • Cost-benefit analysis (CBA)
  • Cost-Effectiveness Analysis (CEA)
  • Cost-Utility Analysis (CUA)
  • Budget Impact Analysis (BIA)
  • Pharmacoeconomic Modeling
  • Real-World Evidence (RWE)
  • Quality of Life Assessment
  • Patient-Reported Outcomes (PROs)
  • Budget Constraints and Affordability
  • Policy and Decision Support
  • Market Access and Reimbursement
  • Sensitivity Analysis
  • Ethical Considerations
19. Pharma Marketing: Pharmaceutical marketing, often referred to as pharma marketing, encompasses the strategies and activities used by pharmaceutical companies to promote and sell their products. It involves various aspects, including advertising, sales, relationship building with healthcare professionals, and compliance with regulatory guidelines.
Here are key aspects of pharmaceutical marketing:
  • Direct-to-Consumer Advertising (DTCA)
  • Sales Representative Interactions
  • Digital Marketing
  • Medical Education and Continuing Medical Education (CME)
  • Branding and Positioning
  • Key Opinion Leader (KOL) Engagement
  • Patient Support Programs
  • Market Research
20. Artificial Intelligence in pharma: Artificial Intelligence (AI) is making significant inroads into the pharmaceutical industry, revolutionizing various aspects of drug discovery, development, manufacturing, and healthcare delivery.
Here are key ways in which AI is being applied in the pharmaceutical sector:
  • Drug Discovery and Development
  • Clinical Trials Optimization
  • Personalized Medicine
  • Drug Manufacturing and Quality Control
21. Global health trends: Several global health trends are shaping the pharmaceutical industry and healthcare landscape. These trends reflect the evolving needs, challenges, and opportunities in healthcare on a global scale.
Here are some key global health trends in the pharmaceutical sector:
  • Digital Health and Telemedicine
  • Personalized Medicine
  • Global Vaccination Initiatives
  • Healthcare Data Analytics
  • Patient-Centric Healthcare
  • Value-Based Healthcare
  • Rise of Biopharmaceuticals
  • Global Health Security
22. Regulatory Affairs: Regulatory affairs in the pharmaceutical industry involve activities and processes related to ensuring compliance with regulatory requirements set by health authorities. The primary goal is to secure approvals for the development, manufacturing, and marketing of pharmaceutical products while maintaining the highest standards of safety, efficacy, and quality.
Here are key aspects of regulatory affairs:
  • Regulatory Strategy Development
  • Regulatory Submissions
  • Clinical Trial Regulatory Compliance
  • Quality Assurance and Good Manufacturing Practice (GMP)
  • Post-Market Surveillance and Reporting
  • Labeling and Packaging Compliance
  • Regulatory Intelligence
  • Interactions with Regulatory Agencies
  • Regulatory Training and Education
  • Regulatory Affairs in Medical Devices
  • Orphan Drug Designation and Expedited Programs
23. Pharmaceutical policy: Pharmaceutical policy refers to the set of government regulations, strategies, and actions designed to influence the development, manufacturing, distribution, and use of pharmaceutical products within a country. The overarching goals of pharmaceutical policy include ensuring access to safe and effective medications, promoting affordability, fostering innovation, and safeguarding public health.
Here are key components and considerations in pharmaceutical policy:
  • Drug Approval and Regulation
  • Price Regulation and Access
  • Intellectual Property Rights and Patents
  • Generic Medicines Promotion
  • Pharmacovigilance and Drug Safety
  • Health Technology Assessment (HTA)
  • Formulary Management
  • R&D Incentives and Innovation
  • Parallel Trade and Importation
  • Pharmacy Practice and Distribution
24. Pharmaceutical education and training: Pharmaceutical education and training play a crucial role in preparing professionals to navigate the complex and dynamic field of pharmaceuticals. This encompasses a broad spectrum, including education for pharmacists, pharmaceutical scientists, regulatory affairs professionals, and other stakeholders.
Here are key aspects of pharmaceutical education and training:
  • Pharmacy Education
  • Pharmaceutical Science Education
  • Pharmaceutical Technology and Manufacturing Education
  • Clinical Research Education
  • Regulatory Affairs Education
  • Pharmacovigilance Training
  • Health Economics and Outcomes Research (HEOR) Education
  • Continuing Education
  • Interdisciplinary Collaboration
  • Global Health Perspectives
  • Ethical and Regulatory Compliance Education
As many pharmaceutical companies expand their consumer operations and roll out a variety of consumer brands, digital marketing will be the next frontier for them. Historically, tight regulatory limitations have stifled marketing innovation in the pharmaceutical sector. Since consumers exclusively relied on their healthcare practitioners for medical knowledge and guidance in the past, pharmaceutical corporations have had little to no connection with their end-users, or patients.
It is important to remember that people are using the internet more frequently to find answers to questions and problems rather than just to socialise online. In fact, looking for health-related information online ranks third in terms of popularity. Patients no longer take a passive approach to treatment these days.
Personalised medicine is a goal that can be accomplished by doctors with the help of pharmacogenomics and pharmacogenomics. The term "personalised medicine" will eventually refer to drugs that are appropriate not just for the proper patient but also for the particular sickness or disease that is affecting that patient. The current state of clinical practise, medication development, and drug regulation provide significant challenges.
 
Pharmacoepidemiology is the study of how drugs are used and their impact on large populations of individuals. It provides estimates of both the positive and negative effects of drugs on a population. Epidemiology and clinical pharmacology are stated to be combined in it.
 
Bioavailability:  The rate and extent to which an active ingredient or active component of a drug product is absorbed and made available at the site of action is known as bioavailability. The area under the blood or plasma concentration-time curve and the highest concentration are typically used to determine the extent and pace of drug absorption, respectively.
Bioequivalence: Two drug products or two drug formulations are said to be bioequivalent or therapeutically equivalent when they have the same therapeutic impact. This indicates that there is no discernible difference in their rates and levels of absorption at the site of action.
The primary benefit of Novel medication Delivery System is regulated medication delivery to the target site, which results in greater efficacy and fewer side effects. It uses two methods  spatial drug delivery, which includes directing a medication to a specific organ or tissue, and temporal drug administration. Various strategies are used in this to control how quickly the medicine is delivered to the target area. With the use of a novel drug delivery system, the medicine is delivered to the target spot in a regulated way for greater effectiveness and fewer adverse effects. It uses two methods: spatial drug delivery, which includes directing a medication to a specific organ or tissue, and temporal drug administration.
 
 
 

 

Market Analysis

Importance & Scope:

The finest venue for presenting and discussing contemporary aspects of drug development is the Pharma Conference 2022. Pharmacology is the study of how chemicals interact with biological things. To maximise the therapeutic benefits and lower the hazards for receivers of medications, it is crucial to talk about the pharmacological basis of therapies. As a result, it will be the ideal venue for academics, researchers, PhD candidates, graduates, and postgraduates working in the creation of new drugs

Global Pharmaceutical Chemicals Market: Key Research Aspects:

The pharmaceutical market is examined and predicted in this paper both globally and regionally. From 2017 through 2025, the market has been predicted based on volume (Tonnes) and revenue (US$ Mn), with 2016 serving as the base year. The worldwide pharmaceutical market's drivers and restraints are covered in the study. It also discusses how these factors will affect the forecasted demand for pharmaceuticals. The paper also identifies market prospects for pharmaceutical compounds both globally and locally.

To Collaborate Scientific Professionals around the World

Conference Date April 18-19, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Pharma Conference 2023 Conference

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by